Expert Pitch
University of Redlands

Following ethical principles in times of wealth and social tranquility is easy. But take the same ethical principles and drop them into a time of scarcity and panic, and the world looks very different, says University of Redlands professor.

15-May-2020 5:30 AM EDT, by University of Redlands

Riaz Tejani is an associate professor of business ethics at the University of Redlands who can comment on ethical business issues rising out of the pandemic.  

"Following ethical principles in times of wealth and social tranquility is easy. People share, businesses honor employees and customers, and governments balance growth with sustainability. But take the same ethical principles and drop them into a time of scarcity and panic, and the world looks very different.  

"The COVID-19 global public health emergency has demonstrated this all too well for a new generation to cringe and learn. Determining 'the right thing to do' has gotten much harder now. Do you keep your business open to serve the public or shutter to protect employees? Do you raise prices on necessities or keep them low to allow easy access—knowing all the while that hoarders will themselves 'buy low and sell high.' And if you’re a member of the United States Senate in possession of early intelligence briefings, do you sell your personal stockholding because you know, before most Americans, that the whole economy is about to plummet?  

"Facing us with such questions like never before, COVID-19 is both a scourge and an opportunity. It is a scourge not only because it is hurting and killing, but because it is doing so to people in near-total isolation from families, friends, communities, and society. Once diagnosed or suspected of having the disease, we are atomized, severed from loved ones and visitors in a way that defies human tendencies to need empathy and care. But it is an opportunity for leaders and organizations to reflect on their values—on the ways that they once construed 'the right thing to do.'

"While the disaster proves to be a moment for ethical self-examination, and one would hope it is used to full advantage, it is probably only the latest in a string of epochal events that include the 2008 financial crisis, and the 2001 9/11 attacks. When it comes to corporate ethics in times of global crisis, we are seeing yet again that heroes aren’t made they are born—and sadly not very often."   

Biography :
Riaz Tejani is an associate professor of business ethics. His research examines problems in legal and business ethics with a focus on race and class inequality, access to justice, and higher education. Riaz's first book, Law Mart: Justice, Access, and For-Profit Law Schools (2017), is an ethnographic account of for-profit legal education during and after the global financial crisis. His second book, Law and Society Today, critically surveys contemporary themes in socio-legal studies after "law and economics". Riaz serves on the National Advisory Council of the non-profit research center Law School Transparency, and his recent articles have appeared in American Ethnologist, U.C. Irvine Law Review, and Political and Legal Anthropology Review. His work has been cited or reviewed in outlets including the Harvard Law Review, Yale Law Journal Forum, Annual Review of Law and Social Science, The Nation, Huffington Post, Salon, and NPR.

Filters close

Showing results

110 of 5634
Newswise: shutterstock_1724336896.jpg
Released: 13-May-2021 12:55 PM EDT
Kreuter receives $1.9 million in grants to increase vaccinations in St. Louis
Washington University in St. Louis

Matthew Kreuter, the Kahn Family Professor of Public Health at the Brown School, has received $1.9 million in grants to help increase COVID-19 vaccinations among Blacks in St. Louis City and County.

Released: 13-May-2021 11:35 AM EDT
COVID-19 mRNA Vaccines are Immunogenic in Pregnant and Lactating Women, Including Against Viral Variants
Beth Israel Deaconess Medical Center

In a new study from Beth Israel Deaconess Medical Center researchers evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. They found that both vaccines triggered immune responses in pregnant and lactating women.

Released: 13-May-2021 10:30 AM EDT
Pandemic stigma: Foreigners, doctors wrongly targeted for COVID-19 spread in India
Monash University

The Indian public blamed foreigners, minority groups and doctors for the rapid spread of COVID-19 across the country during the first wave, due to misinformation, rumour and long-held discriminatory beliefs, according to an international study led by Monash University.

Released: 13-May-2021 9:00 AM EDT
28 Community Programs Receive Grants Through Penn Medicine CAREs Program
Perelman School of Medicine at the University of Pennsylvania

Penn Medicine CAREs awarded grants to 28 projects, many of which aim to fill vast needs in the community created by the COVID-19 pandemic, while others seek to improve diversity, equity, and inclusion.

Released: 13-May-2021 9:00 AM EDT
How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

How to Win Over Vaccine Skeptics: Live Expert Panel for May 20, 3pm ET

Released: 13-May-2021 8:00 AM EDT
Dental procedures during pandemic are no riskier than a drink of water
Ohio State University

A new study’s findings dispel the misconception that patients and providers are at high risk of catching COVID-19 at the dentist’s office.

Newswise:Video Embedded lung-damage-not-the-culprit-for-post-covid-exercise-limitations
Released: 13-May-2021 7:00 AM EDT
Lung Damage Not the Culprit for Post-COVID Exercise Limitations
American Physiological Society (APS)

A new study suggests the lungs may not be the main factor that reduce exercise ability in people recovering from severe COVID-19. Anemia and muscle dysfunction also play a role. The study is published ahead of print in the Journal of Applied Physiology. It was chosen as an APSselect article for May.

Newswise:Video Embedded australia-accelerates-new-covid-19-vaccine-to-fight-mutant-strains
Released: 13-May-2021 2:05 AM EDT
Australia accelerates new COVID-19 vaccine to fight mutant strains
University of South Australia

A leading South Australian immunologist has been awarded $3 million from the Federal Government to accelerate work on a locally developed Covid-19 vaccine, in what's anticipated to be the second line of defence against the virus.

Released: 12-May-2021 5:10 PM EDT
Understanding SARS-COV-2 proteins is key to improve therapeutic options for COVID-19
Bentham Science Publishers

COVID-19 has had a significant impact since the pandemic was declared by WHO in 2020, with over 3 million deaths and counting, Researchers and medical teams have been hard at work at developing strategies to control the spread of the infection, caused by SARS-COV-2 virus and treat affected patients.

Showing results

110 of 5634